Meaning-Centered Pain Coping Skills Training for Cancer Pain
MCPC
1 other identifier
interventional
211
1 country
1
Brief Summary
This study is a randomized controlled trial of a psychosocial pain management intervention called, Meaning-Centered Pain Coping Skills Training (MCPC). Patients with advanced solid tumor cancer and pain interference will be randomized to MCPC or a standard care control condition. Patient-reported outcomes will be assessed at baseline and 8- and 12-week follow-ups. The risk and safety issues in this trial are low and limited to those common to a psychosocial intervention (e.g., loss of confidentiality).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2023
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 27, 2022
CompletedFirst Posted
Study publicly available on registry
May 23, 2022
CompletedStudy Start
First participant enrolled
February 9, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 10, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2026
ExpectedApril 15, 2026
April 1, 2026
3.2 years
April 27, 2022
April 10, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Patient-Reported Outcomes Measurement Information System (PROMIS) Pain Interference-Short Form
This 8-item measure assesses the degree to which, over the past 7 days, pain has interfered with daily activities, work around the home, engagement in social activities, household chores, fun activities, enjoyment of social activities, enjoyment of life, and family life. Response options range from 1 (not at all) to 5 (very much). Higher scores indicate worse pain interference.
8-week follow-up
Secondary Outcomes (9)
Patient-Reported Outcomes Measurement Information System (PROMIS) Pain Interference-Short Form
12-week follow-up
Brief Pain Inventory-Short Form (BPI-SF) Pain Severity Subscale
8-week follow-up and 12-week follow-up
Functional Assessment of Chronic Illness Therapy-Spiritual Well-Being Scale (FACIT-Sp)
8-week follow-up and 12-week follow-up
Patient-Reported Outcomes Measurement Information System (PROMIS) Meaning and Purpose Scale
8-week follow-up and 12-week follow-up
Patient-Reported Outcomes Measurement Information System (PROMIS) Anxiety-Short Form
8-week follow-up and 12-week follow-up
- +4 more secondary outcomes
Other Outcomes (4)
All-cause medical resource use
Baseline, 8-week follow-up, and 12-week follow-up
Participant time
8-week follow-up
Participant productivity
Baseline, 8-week follow-up, and 12-week follow-up
- +1 more other outcomes
Study Arms (2)
Meaning-Centered Pain Coping Skills Training
EXPERIMENTALFour, 45-60 minute, videoconference-delivered sessions focus on training participants in cognitive and behavioral skills (e.g., guided imagery, activity pacing) for managing pain.
Standard Care
NO INTERVENTIONInformation and referrals for free services available through the Duke Cancer Patient Support Program.
Interventions
The goal of this intervention is to help participants reduce pain interference so that they can engage with what gives them a sense of meaning, purpose, and peace.
Eligibility Criteria
You may qualify if:
- Stage IV solid tumor cancer diagnosis
- Eastern Cooperative Oncology Group (ECOG) performance status of 2 or lower
- At least one clinical pain severity rating \> 0 out of 10 in past month
- At least moderate pain interference (8-item Patient-Reported Outcomes Measurement Information System \[PROMIS\] Pain Interference T-score \>/= 55) in the past week at telephone screening
- Ability to speak and read in English
- Age \>/= 18 years.
You may not qualify if:
- Significant cognitive impairment as indicated in medical chart or during telephone screening
- Serious untreated mental illness
- Primary brain cancer diagnosis
- Previous engagement in Pain Coping Skills Training or Meaning-Centered Psychotherapy
- Enrollment in hospice at screening
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Duke Universitylead
- American Cancer Society, Inc.collaborator
Study Sites (1)
Duke Cancer Center
Durham, North Carolina, 27710, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Joseph G Winger, PhD
Duke University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 27, 2022
First Posted
May 23, 2022
Study Start
February 9, 2023
Primary Completion
April 10, 2026
Study Completion (Estimated)
June 1, 2026
Last Updated
April 15, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share